Skip to content

Comparison between the performance of two methods of nasogastric tube insertion in adult patients undergoing surgery under general Anesthesia.

Comparison between Tuoren Video laryngoscope-guided technique and Blind method for nasogastric tube placement in anasesthetised,intubated,adult patients. - NIL

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/04/065739
Enrollment
148
Registered
2024-04-16
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: O- Medical and Surgical

Interventions

Intervention1: Insertion of nasogastric tube using Tuoren Video laryngoscope: To determine the procedure time of successful insertion of nasogastric tube guided by Tuoren video laryngoscope, along wit

Sponsors

Department of Anaesthesiology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Adult above 18 years patients undergoing elective abdominal surgeries that require intra operative nasogastric tube insertion. 2. Patients who have given written informed consent to participate in the study

Exclusion criteria

Exclusion criteria: 1. Anatomical/structural abnormalities such as gross deviated nasal septum, abnormality involving lips and palate. 2. Patients with oral ,nasal ,pharyngeal, oesophageal mass. 3. Patients with significant injuries involving head and neck. 4. Patients with thrombocytopenia or coagulation disorder. 5. Small mouth opening.

Design outcomes

Primary

MeasureTime frame
To determine and compare the procedure time of successful nasogastric tube insertion of both the techniques .Timepoint: Intra operative period(initial stage).

Secondary

MeasureTime frame
1. To determine the proportion of the patients in whom successful nasogastric tube insertion will be possible within first attempt using either of the two methods. 2. To observe the adverse events ,if any.Timepoint: Intra operative period (initial stage)

Countries

India

Contacts

Public ContactDr MOHANCHANDRA MANDAL
drmcmandal@gmail.com9433072820

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026